ELV · Elevance Health, Inc.

Healthcare NYQ United States elevancehealth.com ↗
Val Gro Qua Mom Sta Cap P/S0.45 P/E Fwd P/E14.14 PEG1.30 52W –  RSI Target$450.05 (+7.5%) Beta0.70 Div1.65%
Loading chart…
RSI ()
Pattern Overlays
Loading patterns…
Healthcare Plans Indianapolis, United States 96,129 employees
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low 52W High
Position in Range
RSI (14)
0 · Oversold RSI 61 Overbought · 100
Signal Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
4Bullish
5Bearish
0Neutral

Key Signals 1

▼ Double Top Major reversal 2026-07-16 · $381.24
Two peaks ~$431.61 — bearish reversal confirmed
Learn more →

Momentum Signals 8

▲ MACD Bullish Crossover 2026-06-09 · $422.71
▲ MACD Bullish Crossover 2026-07-02 · $417.89
▲ MACD Bullish Crossover 2026-08-06 · $391.4
▲ MACD Bullish Crossover 2026-09-01 · $403.04

View overlays on the price chart via Overview tab → Pattern Overlays.

Next Earnings Oct 21, 2026
Beat Rate 62%
Consensus BUY
Analyst Upside +7.5%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
62% 5/8 quarters
Wall Street Consensus
BUY
15
7
BuyHoldSell
Price Target Range
$450.05 +7.5% upside
Low $393 High $492
Consensus Current price
Wall Street Analyst Ratings
Sort by
Firm Rating Change Action Date
Profitability
Gross Margin 25.99%Last 12 Months
Operating Margin 4.56%Last 12 Months
Return on Equity 11.13%Last 12 Months
Revenue Growth 1.40%Year over Year
Free Cash Flow 4.31BLast 12 Months
Free Cash Flow Yield Last 12 Months
Balance Sheet
Debt / Equity 68.95Most Recent Quarter
Current Ratio 1.52Most Recent Quarter
Cash 37.51BMost Recent Quarter
Total Debt 31.04BMost Recent Quarter
Net Debt Most Recent Quarter
How ELV Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap90.81B
Enterprise Value84.48B
Trailing P/E18.51
Forward P/E14.14
PEG Ratio (5yr)1.30
Price/Sales (ttm)0.45
Price/Book (mrq)2.02
EV/Revenue0.42
EV/EBITDA10.15
Share Statistics
Avg Vol (3m)1.33M
Shares Outstanding216.87M
Float216.37M
% Held by Insiders0.19%
% Held by Institutions94.13%
Short Ratio6.12
Short % of Float2.83%
Profitability
Gross Margin25.99%
Operating Margin (ttm)4.56%
Profit Margin2.47%
Return on Assets (ttm)3.83%
Return on Equity (ttm)11.13%
Income Statement
Revenue (ttm)201.11B
Revenue Growth (yoy)1.40%
Gross Profit (ttm)52.27B
EBITDA8.32B
Net Income (ttm)4.96B
Diluted EPS (ttm)22.62
EPS Growth (yoy)-13.10%
Balance Sheet
Total Cash (mrq)37.51B
Total Debt (mrq)31.04B
Debt / Equity (mrq)68.95
Current Ratio (mrq)1.52
Book Value / Share206.99
Operating CF (ttm)7.46B
Free Cash Flow (ttm)4.31B
Trading & Dividends
Beta (5Y)0.70
50-Day MA397.20
200-Day MA360.57
Fwd Dividend Yield1.65%
Payout Ratio30.34%
Income
Dividend Yield 1.65%Last 12 Months
Annual Rate 6.88Forward
Payout Ratio 30.34%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 30.34%
Monthly Dividends
Ownership Breakdown
Institutional 94.13% Insider 0.19% Public 5.7%
Short Interest 2.83% of float
Low
Institutional 13F Holdings

Famous investors who disclosed a position in ELV in their latest SEC 13F filing.

Loading…
Insider Transactions
Date Insider Role Transaction Shares Price Value